Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease that significantly impacts quality of life. The pathogenesis of AD is a complex combination of skin barrier dysfunction, type II immune response, and pruritus. Progress in the understanding of the immunological mechanisms of AD has led to...
Main Authors: | Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, Makiko Kido-Nakahara, Takamichi Ito, Takeshi Nakahara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/5/1303 |
Similar Items
-
The Dawn of a New Era in Atopic Dermatitis Treatment
by: Kazuhiko Yamamura, et al.
Published: (2022-10-01) -
Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
by: Gaku Tsuji, et al.
Published: (2023-09-01) -
Pathogenesis of Atopic Dermatitis: Current Paradigm
by: Masutaka Furue, et al.
Published: (2019-06-01) -
JAK/STAT inhibitors for the treatment of atopic dermatitis
by: Maria Alexandra Rodrigues, et al.
Published: (2020-01-01) -
Oral small molecules for the treatment of atopic dermatitis: a systematic review
by: Pezhman Mobasher, et al.
Published: (2019-08-01)